DexCom, Inc. (DXCM)
USD 70.26
(-0.65%)
USD 70.26
(-0.65%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.59 Billion USD | 24.39% |
| 2022 | 2.08 Billion USD | 14.47% |
| 2021 | 1.82 Billion USD | -0.96% |
| 2020 | 1.83 Billion USD | 60.56% |
| 2019 | 1.14 Billion USD | 13.4% |
| 2018 | 1.01 Billion USD | 208.39% |
| 2017 | 327.6 Million USD | 5360.0% |
| 2016 | 6 Million USD | 160.87% |
| 2015 | 2.3 Million USD | -50.0% |
| 2014 | 4.6 Million USD | -32.35% |
| 2013 | 6.8 Million USD | -2.86% |
| 2012 | 7 Million USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 525 Thousand USD | -98.87% |
| 2009 | 46.65 Million USD | -26.36% |
| 2008 | 63.35 Million USD | 1.52% |
| 2007 | 62.4 Million USD | 1962.33% |
| 2006 | 3.02 Million USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 2.43 Billion USD | -0.12% |
| 2024 Q1 | 2.59 Billion USD | -0.15% |
| 2024 Q2 | 2.59 Billion USD | 0.16% |
| 2023 FY | 2.59 Billion USD | 24.39% |
| 2023 Q4 | 2.59 Billion USD | -2.52% |
| 2023 Q2 | 3.31 Billion USD | 54.62% |
| 2023 Q1 | 2.14 Billion USD | 2.75% |
| 2023 Q3 | 2.66 Billion USD | -19.68% |
| 2022 Q1 | 2.14 Billion USD | 17.56% |
| 2022 FY | 2.08 Billion USD | 14.47% |
| 2022 Q2 | 2.13 Billion USD | -0.2% |
| 2022 Q3 | 2.13 Billion USD | -0.25% |
| 2022 Q4 | 2.08 Billion USD | -2.19% |
| 2021 Q1 | 1.87 Billion USD | 1.79% |
| 2021 Q2 | 1.89 Billion USD | 1.15% |
| 2021 Q3 | 1.88 Billion USD | -0.55% |
| 2021 Q4 | 1.82 Billion USD | -3.28% |
| 2021 FY | 1.82 Billion USD | -0.96% |
| 2020 Q3 | 1.81 Billion USD | 4.06% |
| 2020 Q1 | 1.17 Billion USD | 2.85% |
| 2020 Q2 | 1.74 Billion USD | 48.3% |
| 2020 Q4 | 1.83 Billion USD | 1.15% |
| 2020 FY | 1.83 Billion USD | 60.56% |
| 2019 FY | 1.14 Billion USD | 13.4% |
| 2019 Q4 | 1.14 Billion USD | 3.15% |
| 2019 Q3 | 1.11 Billion USD | 2.27% |
| 2019 Q2 | 1.08 Billion USD | 0.61% |
| 2019 Q1 | 1.07 Billion USD | 6.84% |
| 2018 Q1 | 331.3 Million USD | 1.13% |
| 2018 Q3 | 346.1 Million USD | 1.11% |
| 2018 Q4 | 1.01 Billion USD | 191.91% |
| 2018 FY | 1.01 Billion USD | 208.39% |
| 2018 Q2 | 342.3 Million USD | 3.32% |
| 2017 Q2 | 327.2 Million USD | 300.49% |
| 2017 Q4 | 327.6 Million USD | -0.94% |
| 2017 FY | 327.6 Million USD | 5360.0% |
| 2017 Q1 | 81.7 Million USD | 1119.4% |
| 2017 Q3 | 330.7 Million USD | 1.07% |
| 2016 Q4 | 6.7 Million USD | 11.67% |
| 2016 FY | 6 Million USD | 160.87% |
| 2016 Q3 | 6 Million USD | 0.0% |
| 2016 Q2 | 6 Million USD | 252.94% |
| 2016 Q1 | 1.7 Million USD | -26.09% |
| 2015 Q2 | 3.5 Million USD | -14.63% |
| 2015 Q3 | 2.9 Million USD | -17.14% |
| 2015 Q4 | 2.3 Million USD | -20.69% |
| 2015 FY | 2.3 Million USD | -50.0% |
| 2015 Q1 | 4.1 Million USD | -10.87% |
| 2014 FY | 4.6 Million USD | -32.35% |
| 2014 Q2 | 5.8 Million USD | -7.94% |
| 2014 Q3 | 5.2 Million USD | -10.34% |
| 2014 Q4 | 4.6 Million USD | -11.54% |
| 2014 Q1 | 6.3 Million USD | -7.35% |
| 2013 Q4 | 6.8 Million USD | -2.86% |
| 2013 Q3 | 7 Million USD | 0.0% |
| 2013 FY | 6.8 Million USD | -2.86% |
| 2013 Q2 | 7 Million USD | 0.0% |
| 2013 Q1 | 7 Million USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q4 | 7 Million USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2012 FY | 7 Million USD | 0.0% |
| 2011 Q1 | 300 Thousand USD | -42.86% |
| 2011 Q3 | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q2 | 75 Thousand USD | -75.0% |
| 2010 Q4 | 525 Thousand USD | -30.0% |
| 2010 Q1 | 5.86 Million USD | -87.42% |
| 2010 FY | 525 Thousand USD | -98.87% |
| 2010 Q2 | 4.18 Million USD | -28.72% |
| 2010 Q3 | 750 Thousand USD | -82.07% |
| 2009 FY | 46.65 Million USD | -26.36% |
| 2009 Q3 | 45.58 Million USD | 1.5% |
| 2009 Q4 | 46.65 Million USD | 2.36% |
| 2009 Q2 | 44.91 Million USD | 1.39% |
| 2009 Q1 | 44.29 Million USD | -30.09% |
| 2008 Q1 | 65.06 Million USD | 4.26% |
| 2008 FY | 63.35 Million USD | 1.52% |
| 2008 Q2 | 64.49 Million USD | -0.87% |
| 2008 Q4 | 63.35 Million USD | -0.89% |
| 2008 Q3 | 63.92 Million USD | -0.88% |
| 2007 Q2 | 63.09 Million USD | -0.54% |
| 2007 Q4 | 62.4 Million USD | -0.55% |
| 2007 FY | 62.4 Million USD | 1962.33% |
| 2007 Q1 | 63.43 Million USD | 1996.43% |
| 2007 Q3 | 62.75 Million USD | -0.55% |
| 2006 Q2 | 1.5 Million USD | 0.0% |
| 2006 Q3 | 2.7 Million USD | 80.0% |
| 2006 FY | 3.02 Million USD | 0.0% |
| 2006 Q4 | 3.02 Million USD | 12.07% |
| 2006 Q1 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| TriSalus Life Sciences, Inc. | 1.59 Million USD | -162533.229% |
| Anika Therapeutics, Inc. | 29.03 Million USD | -8833.43% |
| Accelerate Diagnostics, Inc. | 39.22 Million USD | -6513.972% |
| BioSig Technologies, Inc. | 452 Thousand USD | -573793.805% |
| AxoGen, Inc. | 69.29 Million USD | -3643.578% |
| Heart Test Laboratories, Inc. | 1.03 Million USD | -250204.437% |
| Integra LifeSciences Holdings Corporation | 1.68 Billion USD | -54.25% |
| INVO Bioscience, Inc. | 8.68 Million USD | -29772.537% |
| IRIDEX Corporation | 2.74 Million USD | -94364.676% |
| MaxCyte, Inc. | 18.74 Million USD | -13739.834% |
| Nuwellis, Inc. | 981 Thousand USD | -264324.057% |
| Aethlon Medical, Inc. | 940.31 Thousand USD | -275764.709% |
| AdaptHealth Corp. | 2.29 Billion USD | -13.046% |
| Apyx Medical Corporation | 38.5 Million USD | -6637.487% |
| PAVmed Inc | 48.72 Million USD | -5223.756% |
| BIOLASE, Inc. | 17.91 Million USD | -14383.529% |
| Biotricity, Inc. | 23.87 Million USD | -10763.197% |
| BrainsWay Ltd. | 471 Thousand USD | -550643.1% |
| Cerus Corporation | 95.99 Million USD | -2602.111% |
| Envoy Medical, Inc. | 404 Thousand USD | -641979.208% |
| RxSight, Inc. | 3.01 Million USD | -86022.178% |
| Cutera, Inc. | 431.91 Million USD | -500.585% |
| Sintx Technologies, Inc. | 4.24 Million USD | -61007.185% |
| Dynatronics Corporation | 6.68 Million USD | -38686.169% |
| electroCore, Inc. | 626 Thousand USD | -414276.997% |
| Telesis Bio, Inc. | 34.38 Million USD | -7445.084% |
| FONAR Corporation | 41.67 Million USD | -6124.225% |
| Helius Medical Technologies, Inc. | 57 Thousand USD | -4550777.193% |
| iCAD, Inc. | 461 Thousand USD | -562589.805% |
| IceCure Medical Ltd | 599 Thousand USD | -432955.092% |
| Inogen, Inc. | 21.92 Million USD | -11732.322% |
| InMode Ltd. | 9.01 Million USD | -28667.883% |
| IRadimed Corporation | 2.04 Million USD | -126867.47% |
| LivaNova PLC | 640.4 Million USD | -305.057% |
| LENSAR, Inc. | 2.3 Million USD | -112243.006% |
| Lucid Diagnostics Inc. | 15.25 Million USD | -16904.261% |
| Spectral AI, Inc. | 1.28 Million USD | -201141.272% |
| Monogram Orthopaedics, Inc. | 491.99 Thousand USD | -527145.417% |
| Modular Medical, Inc. | 1.19 Million USD | -217883.193% |
| Movano Inc. | 252 Thousand USD | -1029265.079% |
| NanoVibronix, Inc. | 5000.00 USD | -51879900.0% |
| Inari Medical, Inc. | 32.04 Million USD | -7994.362% |
| Nemaura Medical Inc. | 20.03 Million USD | -12850.477% |
| NeuroOne Medical Technologies Corporation | 184.4 Thousand USD | -1406624.512% |
| Nano-X Imaging Ltd. | 8.39 Million USD | -30795.665% |
| enVVeno Medical Corporation | 1.4 Million USD | -184921.398% |
| Align Technology, Inc. | 96.96 Million USD | -2575.109% |
| Outset Medical, Inc. | 136.18 Million USD | -1804.72% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -258782.236% |
| PetVivo Holdings, Inc. | 1.36 Million USD | -189931.061% |
| PROCEPT BioRobotics Corporation | 79.2 Million USD | -3175.087% |
| Profound Medical Corp. | 7.9 Million USD | -32733.901% |
| Quipt Home Medical Corp. | 98.94 Million USD | -2521.698% |
| QT Imaging Holdings, Inc. | 3.07 Million USD | -84365.895% |
| Quanterix Corporation | 41.46 Million USD | -6156.029% |
| Rapid Micro Biosystems, Inc. | 7.34 Million USD | -35211.734% |
| SI-BONE, Inc. | 38.99 Million USD | -6552.647% |
| Tactile Systems Technology, Inc. | 50.37 Million USD | -5049.38% |
| TELA Bio, Inc. | 42.78 Million USD | -5963.581% |
| Tivic Health Systems, Inc. | 369 Thousand USD | -702881.03% |
| Talis Biomedical Corporation | 19.66 Million USD | -13088.936% |
| Treace Medical Concepts, Inc. | 70.3 Million USD | -3589.743% |
| Vivani Medical, Inc. | 20.69 Million USD | -12433.823% |
| Bruker Corporation | 1.37 Billion USD | -88.026% |
| Venus Concept Inc. | 79.69 Million USD | -3154.828% |
| Viveve Medical, Inc. | 5.34 Million USD | -48395.046% |
| Viemed Healthcare, Inc. | 10.27 Million USD | -25155.134% |
| ZimVie Inc. | 521.92 Million USD | -397.002% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -110377.002% |
| iRhythm Technologies, Inc. | 129.82 Million USD | -1898.09% |
| Pulmonx Corporation | 41.42 Million USD | -6162.07% |
| Alphatec Holdings, Inc. | 541.67 Million USD | -378.881% |
| Axonics, Inc. | 27.61 Million USD | -9292.765% |
| ReShape Lifesciences Inc. | 262 Thousand USD | -989976.336% |
| NeuroPace, Inc. | 72.39 Million USD | -3483.12% |
| Nexalin Technology, Inc. | 4463.00 USD | -58122239.234% |
| STRATA Skin Sciences, Inc. | 15.63 Million USD | -16493.104% |
| Vivos Therapeutics, Inc. | 1.99 Million USD | -129925.063% |
| UFP Technologies, Inc. | 46.03 Million USD | -5534.598% |
| Varex Imaging Corporation | 469.5 Million USD | -452.503% |
| PAVmed Inc. | 48.72 Million USD | -5223.756% |
| Tandem Diabetes Care, Inc. | 415.66 Million USD | -524.057% |
| Cytek Biosciences, Inc. | 33.17 Million USD | -7719.377% |
| 908 Devices Inc. | 5.94 Million USD | -43533.305% |
| Nexalin Technology, Inc. | 4463.00 USD | -58122239.234% |
| ClearPoint Neuro, Inc. | 13.94 Million USD | -18506.987% |
| Orthofix Medical Inc. | 134.19 Million USD | -1832.95% |
| Surmodics, Inc. | 29.4 Million USD | -8721.629% |
| OrthoPediatrics Corp. | 23.76 Million USD | -10817.508% |
| Semler Scientific, Inc. | 70 Thousand USD | -3705614.286% |
| Cytosorbents Corporation | 18.31 Million USD | -14064.683% |
| DIH Holding US, Inc. Warrants | 1.99 Million USD | -129827.373% |
| DIH Holdings US, Inc. Class A Common Stock | 1.99 Million USD | -129827.373% |
| Sight Sciences, Inc. | 35.41 Million USD | -7224.787% |
| Insulet Corporation | 1.44 Billion USD | -79.045% |
| Beyond Air, Inc. | 17.83 Million USD | -14442.804% |
| Bioventus Inc. | 409.47 Million USD | -533.493% |
| InspireMD, Inc. | 1.59 Million USD | -162533.229% |
| Tenon Medical, Inc. | 1.17 Million USD | -221042.37% |
| CVRx, Inc. | 30.61 Million USD | -8373.524% |
| Acutus Medical, Inc. | 38.47 Million USD | -6641.339% |
| Co-Diagnostics, Inc. | 2.99 Million USD | -86639.404% |
| Inspira Technologies Oxy B.H.N. Ltd. | 2.34 Million USD | -110377.002% |
| Sensus Healthcare, Inc. | 783 Thousand USD | -331189.911% |
| Pacific Biosciences of California, Inc. | 933.93 Million USD | -177.751% |
| TransMedics Group, Inc. | 515.94 Million USD | -402.766% |
| ReWalk Robotics Ltd. | 1.9 Million USD | -136211.088% |
| NeuroMetrix, Inc. | 240.87 Thousand USD | -1076802.639% |
| Hyperfine, Inc. | 185 Thousand USD | -1402062.162% |
| Establishment Labs Holdings Inc. | 192.22 Million USD | -1249.467% |
| Biomerica, Inc. | 785 Thousand USD | -330345.86% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -577007.477% |
| Bluejay Diagnostics, Inc. | 370.1 Thousand USD | -700782.182% |
| Silk Road Medical, Inc | 84.63 Million USD | -2964.998% |